Infection

Article	Citations
First case of COVID-19 complicated with fulminant myocarditis: a case report and insights	330
Risk factors for Covid-19 severity and fatality: a structured literature review	316
Long COVID, a comprehensive systematic scoping review	167
Clinical characteristics of 145 patients with corona virus disease 2019 (COVID-19) in Taizhou, Zhejiang, China	164
COVID-19 outbreak: history, mechanism, transmission, structural studies and therapeutics	148
Epidemiology of SARS-CoV-2	140
COVID-19 in people living with human immunodeficiency virus: a case series of 33 patients	140
Clinical characteristics of COVID-19 in children compared with adults in Shandong Province, China	126
Efficacy of commercial mouth-rinses on SARS-CoV-2 viral load in saliva: randomized control trial in Singapore	120
A highly specific and sensitive serological assay detects SARS-CoV-2 antibody levels in COVID-19 patients that correlate with neutralization	105
Successful containment of COVID-19: the WHO-Report on the COVID-19 outbreak in China	104
State-of-the-art review of secondary pulmonary infections in patients with COVID-19 pneumonia	103
COVID-19 and mucormycosis superinfection: the perfect storm	99
A challenging complication following SARS-CoV-2 infection: a case of pulmonary mucormycosis	97
Waves and variants of SARS-CoV-2: understanding the causes and effect of the COVID-19 catastrophe	93
Long COVID: current definition	85
Higher viral loads in asymptomatic COVID-19 patients might be the invisible part of the iceberg	81
Treatment options for K. pneumoniae, P. aeruginosa and A. baumannii co-resistant to carbapenems, aminoglycosides, polymyxins and tigecycline: an approach based on the mechanisms of resistance to carba	80
Clinical and virological features of first human monkeypox cases in Germany	79
Multidrug-resistant Acinetobacter baumannii infections in COVID-19 patients hospitalized in intensive care unit	79
Studying the pathophysiology of coronavirus disease 2019: a protocol for the Berlin prospective COVID-19 patient cohort (Pa-COVID-19)	75
Differences and similarities between SARS-CoV and SARS-CoV-2: spike receptor-binding domain recognition and host cell infection with support of cellular serine proteases	74
Metagenomic next-generation sequencing in the diagnosis of severe pneumonias caused by Chlamydia psittaci	73
C-reactive protein and procalcitonin for antimicrobial stewardship in COVID-19	69
Perceived versus proven SARS-CoV-2-specific immune responses in health-care professionals	64

Increasing influenza vaccination coverage in healthcare workers: a review on campaign strategies and their effect	60
Bacterial coinfection in critically ill COVID-19 patients with severe pneumonia	59
Remdesivir in Coronavirus Disease 2019 (COVID-19) treatment: a review of evidence	58
Pulmonary function in patients surviving to COVID-19 pneumonia	58
Recommendations for screening, monitoring, prevention, and prophylaxis of infections in adult and pediatric patients receiving CAR T-cell therapy: a position paper	57
SARS-CoV-2 spike protein: pathogenesis, vaccines, and potential therapies	57
Older age groups and country-specific case fatality rates of COVID-19 in Europe, USA and Canada	55
Recurrence of COVID-19 after recovery: a case report from Italy	52
Cardiac manifestations of COVID-19 in Shenzhen, China	50
COVID-19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational study	50
COVID-19: persistence of symptoms and lung alterations after 3–6 months from hospital discharge	49
First results of the “Lean European Open Survey on SARS-CoV-2-Infected Patients (LEOSS)”	49
CD169/SIGLEC1 is expressed on circulating monocytes in COVID-19 and expression levels are associated with disease severity	46
Contribution of anosmia and dysgeusia for diagnostic of COVID-19 in outpatients	46
Strongyloides infection manifested during immunosuppressive therapy for SARS-CoV-2 pneumonia	44
Comparing the clinical characteristics and outcomes of COVID-19-associate pulmonary aspergillosis (CAPA): a systematic review and meta-analysis	43
SARS-CoV-2-directed antibodies persist for more than six months in a cohort with mild to moderate COVID-19	43
Waning antibody responses in COVID-19: what can we learn from the analysis of other coronaviruses?	43
IgG antibody response against nucleocapsid and spike protein post-SARS-CoV-2 infection	40
Evaluating the clinical utility and sensitivity of SARS-CoV-2 antigen testing in relation to RT-PCR Ct values	40
Efficacy and safety of remdesivir in hospitalised COVID-19 patients: a systematic review and meta-analysis	40
Sequelae of COVID-19 among previously hospitalized patients up to 1 year after discharge: a systematic review and meta-analysis	39
Left and right ventricular dysfunction in patients with COVID-19-associated myocardial injury	39
The current therapeutical strategies in human brucellosis	38
Antibiotics in the pipeline: a literature review (2017–2020)	38
Intrinsic resistance to terbinafine among human and animal isolates of Trichophyton mentagrophytes related to amino acid substitution in the squalene epoxidase	37
Monkeypox in-patients with severe anal pain	37
Co-infection of SARS-CoV-2 with Chlamydia or Mycoplasma pneumoniae: a case series and review of the literature	36
Severe monkeypox-virus infection in undiagnosed advanced HIV infection	34
Characteristics of viral pneumonia in the COVID-19 era: an update	34
Comparison of fatigue, cognitive dysfunction and psychological disorders in post-COVID patients and patients after sepsis: is there a specific constellation?	33
Humoral response to SARS-CoV-2 vaccines in people living with HIV	32
Detection of SARS-CoV-2 in conjunctival secretions from patients without ocular symptoms	31
Hospital at home for the management of COVID-19: preliminary experience with 63 patients	31
Herpes zoster and COVID-19 infection: a coincidence or a causal relationship?	30
Prognostic value of serum amyloid A in patients with COVID-19	30
Emerging echinocandin-resistant Candida albicans and glabrata in Switzerland	30
Key summary of German national treatment guidance for hospitalized COVID-19 patients	29
Secondary tension pneumothorax in a COVID-19 pneumonia patient: a case report	29
Bacterial infections in critically ill patients with SARS-2-COVID-19 infection: results of a prospective observational multicenter study	28
Adenovirus diseases: a systematic review and meta-analysis of 228 case reports	28
The epidemiological burden and overall distribution of chronic comorbidities in coronavirus disease-2019 among 202,005 infected patients: evidence from a systematic review and meta-analysis	28
Pulmonary function impairment of asymptomatic and persistently symptomatic patients 4 months after COVID-19 according to disease severity	27
Obesity and lipid metabolism disorders determine the risk for development of long COVID syndrome: a cross-sectional study from 50,402 COVID-19 patients	27
Serum citrullinated histone H3 concentrations differentiate patients with septic verses non-septic shock and correlate with disease severity	27
An approach to lifting self-isolation for health care workers with prolonged shedding of SARS-CoV-2 RNA	27
Preoperative synovial fluid culture poorly predicts the pathogen causing periprosthetic joint infection	27
COVID-19 anosmia and gustatory symptoms as a prognosis factor: a subanalysis of the HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID-19) registry	26
Early-onset symptomatic neonatal COVID-19 infection with high probability of vertical transmission	25
The rising of old foes: impact of lockdown periods on “non-SARS-CoV-2” viral respiratory and gastrointestinal infections	24

Baricitinib as rescue therapy in a patient with COVID-19 with no complete response to sarilumab	24
Long-term changes in pulmonary function among patients surviving to COVID-19 pneumonia	24
State-of-the-art on monkeypox virus: an emerging zoonotic disease	24
Brief report: attitudes towards Covid-19 vaccination among hospital employees in a tertiary care university hospital in Germany in December 2020	24
Clinical and virological characteristics of hospitalised COVID-19 patients in a German tertiary care centre during the first wave of the SARS-CoV-2 pandemic: a prospective observational study	24
Treatment of fracture-related infection of the lower extremity with antibiotic-eluting ceramic bone substitutes: case series of 35 patients and literature review	23
Immunity after COVID-19 and vaccination: follow-up study over 1 year among medical personnel	23
Selective toxicity of antibacterial agents—still a valid concept or do we miss chances and ignore risks?	23
A simple algorithm helps early identification of SARS-CoV-2 infection patients with severe progression tendency	23
COVID-19 in patients with HIV-1 infection: a single-centre experience in northern Italy	22
Evaluation of accuracy, exclusivity, limit-of-detection and ease-of-use of LumiraDx™: An antigen-detecting point-of-care device for SARS-CoV-2	22
Narrative review of the relationship between COVID-19 and PJP: does it represent coinfection or colonization?	22
Outcome of spinal implant-associated infections treated with or without biofilm-active antibiotics: results from a 10-year cohort study	22
COVID-19: vaccination vs. hospitalization	21
Clustering analysis reveals different profiles associating long-term post-COVID symptoms, COVID-19 symptoms at hospital admission and previous medical co-morbidities in previously hospitalized COVID-1	21
Longitudinal prediction of hospital-acquired acute kidney injury in COVID-19: a two-center study	21
SARS-CoV-2 and Europe: timing of containment measures for outbreak control	21
Clinical characteristics of 194 cases of COVID-19 in Huanggang and Taian, China	21
Long-term health sequelae and quality of life at least 6 months after infection with SARS-CoV-2: design and rationale of the COVIDOM-study as part of the NAPKON population-based cohort platform (POP)	21
Early experience with remdesivir in SARS-CoV-2 pneumonia	21
One-year evolution of DLCO changes and respiratory symptoms in patients with post COVID-19 respiratory syndrome	19
Influence of microbiological diagnosis on the clinical course of spondylodiscitis	19
Absent immune response to SARS-CoV-2 in a 3-month recurrence of coronavirus disease 2019 (COVID-19) case	19
Infections causing stroke or stroke-like syndromes	18
DFV890: a new oral NLRP3 inhibitor—tested in an early phase 2a randomised clinical trial in patients with COVID-19 pneumonia and impaired respiratory function	18
Dalbavancin as long-term suppressive therapy for patients with Gram-positive bacteremia due to an intravascular source—a series of four cases	18
CRISPR-based strategies in infectious disease diagnosis and therapy	18
Variation in the seasonality of the respiratory syncytial virus during the COVID-19 pandemic	17
Predictors of intensive care unit admission in patients with Legionella pneumonia: role of the time to appropriate antibiotic therapy	17
Torque Teno Virus plasma level as novel biomarker of retained immunocompetence in HIV-infected patients	17
Deciphering the epidemiology of invasive candidiasis in the intensive care unit: is it possible?	17
Prediction of COVID-19 deterioration in high-risk patients at diagnosis: an early warning score for advanced COVID-19 developed by machine learning	17
The importance of SHBG and calculated free testosterone for the diagnosis of symptomatic hypogonadism in HIV-infected men: a single-centre real-life experience	17
On the death of 100 + Italian doctors from COVID-19	17
Clinical course and risk factors for severe COVID-19 among Italian patients with cystic fibrosis: a study within the Italian Cystic Fibrosis Society	17
Evidence mapping and review of long-COVID and its underlying pathophysiological mechanism	16
COVID-19-associated Cryptococcus infection (CACI): a review of literature and clinical pearls	16
Self-sampling versus health care professional-guided swab collection for SARS-CoV-2 testing	16
Systematic review and meta-analysis of the proportion and associated mortality of polymicrobial (vs monomicrobial) pulmonary and bloodstream infections by Acinetobacter baumannii complex	16
Baricitinib combination therapy: a narrative review of repurposed Janus kinase inhibitor against severe SARS-CoV-2 infection	16
Reactive arthritis occurring after COVID-19 infection: a narrative review	16
Shift in bacterial etiology from the CAPNETZ cohort in patients with community-acquired pneumonia: data over more than a decade	16
Hemophagocytic lymphohistiocytosis after SARS-CoV-2 vaccination	16
Unusual dermatomycoses caused by Nannizzia nana: the geophilic origin of human infections	16
Comparison of clinical features and outcomes in COVID-19 and influenza pneumonia patients requiring intensive care unit admission	15
Epidemiology and in vitro activity of ceftazidime–avibactam, meropenem–vaborbactam, imipenem–relebactam, eravacycline, plazomicin, and comparators against Greek carbapenemase-producing Klebsiella pneu	15
Post-COVID-19 condition is not only a question of persistent symptoms: structured screening including health-related quality of life reveals two separate clusters of post-COVID	15
Worldwide inverse correlation between Bacille Calmette–Guérin (BCG) immunization and COVID-19 mortality	15
Personalized machine learning approach to predict candidemia in medical wards	15
National Early Warning Score 2 (NEWS2) better predicts critical Coronavirus Disease 2019 (COVID-19) illness than COVID-GRAM, a multi-centre study	15
Impact of an Antimicrobial Stewardship Program-bundled initiative utilizing Accelerate Pheno™ system in the management of patients with aerobic Gram-negative bacilli bacteremia	14
Renin–angiotensin system inhibitors and mortality in patients with COVID-19	14
Ceftazidime/avibactam and ceftolozane/tazobactam for the treatment of extensively drug-resistant Pseudomonas aeruginosa post-neurosurgical infections: three cases and a review of the literature	14
Renal involvement in COVID-19: focus on kidney transplant sector	14
In-depth profiling of COVID-19 risk factors and preventive measures in healthcare workers	14
Fatal vaccine-induced immune thrombotic thrombocytopenia (VITT) post Ad26.COV2.S: first documented case outside US	14
Real-time PCR Ct value in SARS-CoV-2 detection: RdRp or N gene?	13
Impact of SARS-CoV-2 viral load and duration of symptoms before hospital admission on the mortality of hospitalized COVID-19 patients	13
Sex differences in COVID-19 mortality in the Netherlands	13
Myocarditis in admitted patients with dengue fever	13
A review of outbreaks of cryptosporidiosis due to unpasteurized milk	13
Effects of a 4-year intervention on hand hygiene compliance and incidence of healthcare associated infections: a longitudinal study	12
The emergence of Staphylococcus aureus as the primary cause of cardiac device-related infective endocarditis	12
Seroprevalence of anti-SARS-CoV-2 total antibody is higher in younger Austrian blood donors	12
Management of children with fever and neutropenia: results of a survey in 51 pediatric cancer centers in Germany, Austria, and Switzerland	12
Post‐COVID-19 syndrome: assessment of short- and long-term post-recovery symptoms in recovered cases in Saudi Arabia	12
Non-invasive ventilation versus mechanical ventilation in hypoxemic patients with COVID-19	12
Mono vs. combo regimens with novel beta-lactam/beta-lactamase inhibitor combinations for the treatment of infections due to carbapenemase-producing Enterobacterales: insights from the literature	12
Cardiac iron overload promotes cardiac injury in patients with severe COVID-19	12
Implication of the emergence of the delta (B.1.617.2) variants on vaccine effectiveness	12
Respiratory muscle dysfunction in long-COVID patients	12
Concurrent cavitary pulmonary tuberculosis and COVID-19 pneumonia with in vitro immune cell anergy	12
Cidofovir for treating complicated monkeypox in a man with acquired immune deficiency syndrome	12
SOFA and qSOFA usefulness for in-hospital death prediction of elderly patients admitted for suspected infection in internal medicine	12
The proportion, species distribution and dynamic trends of bloodstream infection cases in a tertiary hospital in China, 2010–2019	12
SARS-CoV-2 variants and the risk of pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 among children in Germany	12
The presenting characteristics of erythema migrans vary by age, sex, duration, and body location	11
Gut and airway microbiota and their role in COVID-19 infection and pathogenesis: a scoping review	11
A simple risk score for mortality including the PCR Ct value upon admission in patients hospitalized due to COVID-19	11
Surgical Site Infections after glioblastoma surgery: results of a multicentric retrospective study	11

Successful management of the first reported case in Austria of COVID-19 with ARDS	11
High burden of RSV hospitalizations in Germany 2021–2022	11
Continuous infusion of ceftolozane-tazobactam resulted in high cerebrospinal fluid concentrations of ceftolozane in a patient with multidrug-resistant Pseudomonas aeruginosa meningitis	11
COVID-19 in young and middle-aged adults: predictors of poor outcome and clinical differences	11
Glucocorticoid versus immunoglobulin in the treatment of COVID-19-associated fulminant myocarditis	11
Case series of cefiderocol for salvage therapy in carbapenem-resistant Gram-negative infections	11
Prevalence of integrase strand transfer inhibitor (INSTIs) resistance mutations in Henan Province, China (2018–2020)	11
Molnupiravir for the treatment of COVID-19 in immunocompromised participants: efficacy, safety, and virology results from the phase 3 randomized, placebo-controlled MOVe-OUT trial	10
Observed transaminitis with a unique bacteriophage therapy protocol to treat recalcitrant Staphylococcal biofilm infections	10
In search for a synergistic combination against pandrug-resistant A. baumannii; methodological considerations	10
Coronavirus: a comparative analysis of detection technologies in the wake of emerging variants	10
Hospitalization for Chagas disease, dengue, filariasis, leishmaniasis, schistosomiasis, strongyloidiasis, and Taenia solium taeniasis/cysticercosis, Italy, 2011–2016	10
SARS-CoV-2: big seroprevalence data from Pakistan—is herd immunity at hand?	10
Differential efficacy and safety of anti-SARS-CoV-2 antibody therapies for the management of COVID-19: a systematic review and network meta-analysis	10
Update of clinical application in ceftazidime–avibactam for multidrug-resistant Gram-negative bacteria infections	10
The clinical value of the endocarditis team: insights from before and after guidelines implementation strategy	10
Clinical and epidemiological data of COVID-19 from Regensburg, Germany: a retrospective analysis of 1084 consecutive cases	10
The second dose of the BNT162b2 mRNA vaccine does not boost SARS-CoV-2 neutralizing antibody response in previously infected subjects	10
Duodenal tropism of SARS-CoV-2 and clinical findings in critically ill COVID-19 patients	9
Remdesivir in Coronavirus Disease 2019 patients treated with anti-CD20 monoclonal antibodies: a case series	9
Characteristics and outcomes of acute hepatitis of unknown etiology in Egypt: first report of adult adenovirus-associated hepatitis	9
Life expectancy of HIV-infected patients followed at the largest hospital in Guinea-Bissau is one-fourth of life expectancy of the background population	9
Treatment modification after starting cART in people living with HIV: retrospective analysis of the German ClinSurv HIV Cohort 2005–2017	9
Association between high vancomycin minimum inhibitory concentration and clinical outcomes in patients with methicillin-resistant Staphylococcus aureus bacteremia: a meta-analysis	9
Humoral immunity in dually vaccinated SARS-CoV-2-naïve individuals and in booster-vaccinated COVID-19-convalescent subjects	9
Diagnosis of COVID-19 using multiple antibody assays in two cases with negative PCR results from nasopharyngeal swabs	9
Comparative virulence of seasonal viruses responsible for lower respiratory tract infections: a southern European multi-centre cohort study of hospital admissions	9
Predictive model for bacterial co-infection in patients hospitalized for COVID-19: a multicenter observational cohort study	9
Perinatal transmission of SARS-CoV-2 and transfer of maternal IgG/neutralizing anti-SARS-CoV-2 antibodies from mothers with asymptomatic infection during pregnancy	9
First case of Candida auris isolated from the bloodstream of a Mexican patient with serious gastrointestinal complications from severe endometriosis	9
Coronavirus disease 2019 and peripheral blood eosinophil counts: a retrospective study	9
Characterization of antimicrobial use and co-infections among hospitalized patients with COVID-19: a prospective observational cohort study	9
Age, COVID-19-like symptoms and SARS-CoV-2 seropositivity profiles after the first wave of the pandemic in France	9
Effectiveness of extended shutdown measures during the ´Bundesnotbremse´ introduced in the third SARS-CoV-2 wave in Germany	9
Outcome of lung transplant recipients infected with SARS-CoV-2/Omicron/B.1.1.529: a Nationwide German study	9
A 2-year retrospective analysis of the prognostic value of MqSOFA compared to lactate, NEWS and qSOFA in patients with sepsis	9
Surgery and outcome of infective endocarditis in octogenarians: prospective data from the ESC EORP EURO-ENDO registry	9
Diagnostic accuracy of the interferon-gamma release assay in acquired immunodeficiency syndrome patients with suspected tuberculosis infection: a meta-analysis	9
Changes in T-lymphocyte subsets and risk factors in human immunodeficiency virus-negative patients with active tuberculosis	9
Comprehensive estimation for the length and dispersion of COVID-19 incubation period: a systematic review and meta-analysis	9
Increased risk of death in COVID-19 hospital admissions during the second wave as compared to the first epidemic wave: a prospective, single-centre cohort study in London, UK	8
Analysis of clinical characteristics and prognosis of talaromycosis (with or without human immunodeficiency virus) from a non-endemic area: a retrospective study	8
Chronic wounds in Sierra Leone: pathogen spectrum and antimicrobial susceptibility	8
Will the COVID-19 pandemic slow down in the Northern hemisphere by the onset of summer? An epidemiological hypothesis	8
HIV-1 recombinant forms in immigrants regularly residing in Milan, northern Italy	8
Treatment of COVID-19 with monoclonal antibodies casirivimab and imdevimab in pregnancy	8
High effectiveness of recommended first-line antiretroviral therapies in Germany: a nationwide, prospective cohort study	8
Incidence and risk factors for early readmission after hospitalization for SARS-CoV-2 infection: results from a retrospective cohort study	8
Incidence of bloodstream infections due to multidrug-resistant pathogens in ordinary wards and intensive care units before and during the COVID-19 pandemic: a real-life, retrospective observational st	8
Use of monoclonal antibody therapy for nosocomial SARS-CoV-2 infection in patients at high risk for severe COVID-19: experience from a tertiary-care hospital in Germany	8
Haematological changes in Schistosoma haematobium infections in school children in Gabon	8
COVID-19-associated pulmonary aspergillosis (CAPA) in Iranian patients admitted with severe COVID-19 pneumonia	8
Micronutrient therapy and effective immune response: a promising approach for management of COVID-19	8
Use and effectiveness of remdesivir for the treatment of patients with covid-19 using data from the Lean European Open Survey on SARS-CoV-2 infected patients (LEOSS): a multicentre cohort study	8
Plasmodium cynomolgi in humans: current knowledge and future directions of an emerging zoonotic malaria parasite	8
Evaluation of a multiplex PCR screening approach to identify community-acquired bacterial co-infections in COVID-19: a multicenter prospective cohort study of the German competence network of communit	8
Risk for infective endocarditis in bacteremia with Gram positive cocci	8
Management of Helicobacter pylori infection in paediatric patients in Europe: results from the EuroPedHp Registry	8
Abiotrophia defectiva as a cause of infective endocarditis with embolic complications in children	8
Global epidemiology of childhood bone and joint infection: a systematic review	7
Detection of diphtheria toxin production by toxigenic corynebacteria using an optimized Elek test	7
Clinical and economic effects of an antimicrobial stewardship intervention in a surgical intensive care unit	7
Individualizing the use of [18F]FDG-PET/CT in patients with complicated Staphylococcus aureus bacteremia: experiences from a tertiary care center	7
COVID-19: fighting the foe with Virchow	7
HIV and SARS-CoV-2 co-infection: cross-sectional findings from a German ‘hotspot’	7
Different types of bullae of limbs with necrotizing fasciitis predict different outcome: a prospective study	7
Epidemiologic and clinical characteristics of infective endocarditis: a single-center retrospective study in the Bronx, New York	7
Clinical course and predictive risk factors for fatal outcome of SARS-CoV-2 infection in patients with chronic kidney disease	7
Rapid comparative evaluation of SARS-CoV-2 rapid point-of-care antigen tests	7
Bedside risk prediction for positive follow-up blood culture in Gram-negative bacilli bacteremia: for whom is follow-up blood culture useful?	7
Clinical management of ageing people living with HIV in Europe: the view of the care providers	7
Rapid antigen testing and non-infectious shedding of SARS-Cov2	7
Perspective on the challenges of COVID-19 facing healthcare workers	7
Prevalence and species distribution of Candida bloodstream infection in children and adults in two teaching university hospitals in Egypt: first report of Candida kefyr	7
Comparing SARS-CoV-2 variants among children and adolescents in Germany: relative risk of COVID-19-related hospitalization, ICU admission and mortality	7
COVID-19 is not “just another flu”: a real-life comparison of severe COVID-19 and influenza in hospitalized patients in Vienna, Austria	7
Mycobacterium bovis infection of an aortobifemoral bypass graft with Streptococcus intermedius superinfection after intravesical bacillus Calmette-Guérin immunotherapy for bladder cancer	7
A cost of illness study of COVID-19 patients and retrospective modelling of potential cost savings when administering remdesivir during the pandemic “first wave” in a German tertiary care hospital	7
SARS-CoV-2 infection: a hurricane that does not ignore chronic hepatitis	7
Epigenetic perspectives associated with COVID-19 infection and related cytokine storm: an updated review	7
Real-life experience with fidaxomicin in Clostridioides difficile infection: a multicentre cohort study on 244 episodes	7
The Shapiro–Procalcitonin algorithm (SPA) as a decision tool for blood culture sampling: validation in a prospective cohort study	7
The humoral immune response more than one year after SARS-CoV-2 infection: low detection rate of anti-nucleocapsid antibodies via Euroimmun ELISA	7
Seroprevalence of SARS-CoV-2 in German secondary schools from October 2020 to July 2021: a longitudinal study	7
The impact of antibiotics on clinical response over time in uncomplicated cellulitis: a systematic review and meta-analysis	7
COVID-19, equipoise and observational studies: a reminder of forgotten issues	6
Usefulness of ultrasound in sub-Saharan patients with a serological diagnosis of schistosomiasis	6
Evaluation of a point-of-care molecular detection device for Leishmania spp. and intercurrent fungal and mycobacterial organisms in Peruvian patients with cutaneous ulcers	6
Outcomes of adults with invasive meningococcal disease with reduced penicillin susceptibility in Auckland 2004–2017	6
Durability of anti-spike antibodies after vaccination with mRNA SARS-CoV-2 vaccine is longer in subjects with previous infection: could the booster dose be delayed?	6
Clinical relevance and impact of Corynebacterium isolation in lower respiratory tract of critically ill patients requiring mechanical ventilation	6
New EUCAST definitions of S, I and R from 2019 – German physicians are largely not aware of the changes	6
Declining COVID-19 morbidity and case fatality in Germany: the pandemic end?	6
Clostridioides difficile infections in the intensive care unit: a monocentric cohort study	6
Extended-spectrum beta-lactamase (ESBL) producing Enterobacterales in stool surveillance cultures of preterm infants are no risk factor for necrotizing enterocolitis: a retrospective case–control stud	6